This Week on NeurologyLive

Every week, the NeurologyLive staff prepares this preview of what to expect from our coverage. This week on NeurologyLive, there are a number of hot topics that we will be posting throughout the week.

The NeurologyLive Peer Exchange series, "Advances in the Management of Acute Treatment of Migraine," which features a panel of experts including Peter J. Goadsby, MD, PhD, DSc; Dawn C. Buse, PhD; Jelena Pavlovic, MD, PhD; Wade M. Cooper, DO; and Paul G. Mathew, MD, wraps up with its final episode on Monday, November 9, 2020. In it, Buse discusses some of the behavioral and lifestyle strategies that can be utilized for migraine management.

To view the entire series, click here.

The final episode from the “Case-Based Insights: Expert Perspectives on the Treatment of Epilepsy” series featuring Amit Verma, MD, and Trevor Resnick, MD, who review challenging epilepsy cases and their best practices for the treatment course, will publish on Tuesday, November 10, 2020. In it, Resnick, an expert in the management of epilepsy, provides advice for community neurologists on how to care for patients who are unresponsive to therapy, and when to refer them to a specialty center.

To check out the whole series, click here.

Our new Q&A series dedicated to conversations with leaders in the neurology community, called NeuroVoices, features insight from James Beck, PhD, chief scientific officer, Parkinson’s Foundation. In the conversation, which will go live on Wednesday, November 11, 2020, Beck discussed the recent funding secured for the foundations' PD GENEration initiative and offered his perspective on the current landscape and understanding of genetic testing in Parkinson disease.

To check out the prior NeuroVoices conversations, click here.

A conversation with Jacqueline A. French, MD, professor of neurology, and director, translational research and clinical trials for epilepsy, NYU Langone Health​, will air on NeurologyLive's segment on the Medical World News channel this Thursday, November 12, 2020. French discussed the study results that suggest that overcoming the challenges obstructing earlier diagnosis of focal epilepsy can prevent the morbidity-related consequences of the delays in identifying new-onset disease, such as motor vehicle accidents.

To read more about the study findings, click here.